Anaplastic thyroid carcinoma

Area of Science:

• Oncology
• Surgical Oncology
• Radiation Oncology

Background:

• Anaplastic thyroid carcinoma (ATC) is a rare, aggressive malignancy with a poor prognosis.
• Investigating optimal treatment is challenging due to the rarity and rapid progression of ATC.

Purpose of the Study:

• To review the current evidence for multimodality treatment approaches in anaplastic thyroid carcinoma.
• To discuss the role of surgery, chemotherapy, and radiotherapy in managing localized and advanced ATC.

Main Methods:

• Review of existing literature on anaplastic thyroid carcinoma treatment.
• Analysis of outcomes associated with combined modality therapies.

Main Results:

• Multimodality treatment (surgery, chemotherapy, radiotherapy) is preferred for localized ATC.
• Complete surgical resection followed by chemoradiation can rarely achieve long-term survival.
• Isolated therapies are generally ineffective for local and regional ATC control.

Conclusions:

• Aggressive multimodality treatment, including surgery, chemotherapy, and radiotherapy, is crucial for managing anaplastic thyroid carcinoma.
• While organ preservation is a goal, radical resection may be necessary in selected cases.
• Palliative chemoradiation and surgery can be considered for incurable disease to prevent asphyxiation.